124 related articles for article (PubMed ID: 8654859)
1. Thymidylate synthase as a target in cancer chemotherapy.
Peters GJ; van der Wilt CL
Biochem Soc Trans; 1995 Nov; 23(4):884-8. PubMed ID: 8654859
[No Abstract] [Full Text] [Related]
2. Kinetics of Plasmodium falciparum thymidylate synthase: interactions with high-affinity metabolites of 5-fluoroorotate and D1694.
Hekmat-Nejad M; Rathod PK
Antimicrob Agents Chemother; 1996 Jul; 40(7):1628-32. PubMed ID: 8807052
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of thymitaq (AG337) and 5-fluoro-2-deoxyuridylate-resistant mutants of human thymidylate synthase from ethyl methanesulfonate-exposed human sarcoma HT1080 cells.
Tong Y; Liu-Chen X; Ercikan-Abali EA; Capiaux GM; Zhao SC; Banerjee D; Bertino JR
J Biol Chem; 1998 May; 273(19):11611-8. PubMed ID: 9565579
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of acquired resistance to thymidylate synthase inhibitors: the role of enzyme stability.
Kitchens ME; Forsthoefel AM; Barbour KW; Spencer HT; Berger FG
Mol Pharmacol; 1999 Nov; 56(5):1063-70. PubMed ID: 10531414
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamic study of the interaction of methotrexate, its metabolites, and new antifolates with thymidylate synthase: influence of FdUMP.
Gilli R; Lopez C; Sari JC; Briand C
Biochem Pharmacol; 1990 Nov; 40(10):2241-6. PubMed ID: 2244925
[TBL] [Abstract][Full Text] [Related]
8. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
Calvert H
Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
[No Abstract] [Full Text] [Related]
9. Development and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid (BGC 945), a novel thymidylate synthase inhibitor that targets tumor cells.
Tochowicz A; Dalziel S; Eidam O; O'Connell JD; Griner S; Finer-Moore JS; Stroud RM
J Med Chem; 2013 Jul; 56(13):5446-55. PubMed ID: 23710599
[TBL] [Abstract][Full Text] [Related]
10. Antifolate metabolism and sites of action: implications for the design of new antifolates.
Fitzhugh AL; Chabner BA; Sholar PW; Baram J; Allegra CJ
NCI Monogr; 1987; (5):153-7. PubMed ID: 3431590
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and interactions with thymidylate synthase of 2,4-dithio analogues of dUMP and 5-fluoro-dUMP.
Dzik JM; Bretner M; Kulikowski T; Gołos B; Jarmuła A; Poznański J; Rode W; Shugar D
Biochim Biophys Acta; 1996 Mar; 1293(1):1-8. PubMed ID: 8652614
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase inhibitors.
Ackland SP; Clarke SJ; Beale P; Peters GJ
Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
[No Abstract] [Full Text] [Related]
13. Stereochemical mechanism of action for thymidylate synthase based on the X-ray structure of the covalent inhibitory ternary complex with 5-fluoro-2'-deoxyuridylate and 5,10-methylenetetrahydrofolate.
Matthews DA; Villafranca JE; Janson CA; Smith WW; Welsh K; Freer S
J Mol Biol; 1990 Aug; 214(4):937-48. PubMed ID: 2201779
[TBL] [Abstract][Full Text] [Related]
14. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase.
Morgan RG
Cancer; 1989 Mar; 63(6 Suppl):1008-12. PubMed ID: 2521810
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant variants of Escherichia coli thymidylate synthase: effects of substitutions at Pro-254.
Fantz C; Shaw D; Jennings W; Forsthoefel A; Kitchens M; Phan J; Minor W; Lebioda L; Berger FG; Spencer HT
Mol Pharmacol; 2000 Feb; 57(2):359-66. PubMed ID: 10648646
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthetase - a target enzyme in cancer chemotherapy.
Danenberg PV
Biochim Biophys Acta; 1977 Dec; 473(2):73-92. PubMed ID: 145246
[No Abstract] [Full Text] [Related]
17. Sulfamide antifolates inhibiting thymidylate synthase: synthesis, enzyme inhibition and cytotoxicity.
Pawełczak K; Makowski M; Kempny M; Dzik JM; Gołos B; Rode W; Rzeszotarska B
Acta Biochim Pol; 2002; 49(2):407-20. PubMed ID: 12362982
[TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus 8 gene encodes a functional thymidylate synthase.
Gáspár G; De Clercq E; Neyts J
J Virol; 2002 Oct; 76(20):10530-2. PubMed ID: 12239332
[TBL] [Abstract][Full Text] [Related]
19. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
Sayre PH; Finer-Moore JS; Fritz TA; Biermann D; Gates SB; MacKellar WC; Patel VF; Stroud RM
J Mol Biol; 2001 Nov; 313(4):813-29. PubMed ID: 11697906
[TBL] [Abstract][Full Text] [Related]
20. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
